{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:31:28Z","timestamp":1790685088898,"version":"4.1.0"},"reference-count":121,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10429","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T07:48:21Z","timestamp":1561535301000},"source":"Crossref","is-referenced-by-count":4,"title":["Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review)"],"prefix":"10.3892","author":[{"given":"Paola","family":"Di Benedetto","sequence":"first","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila I\u201167100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila I\u201167100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila I\u201167100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[{"name":"Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7TF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila I\u201167100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila I\u201167100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"key20200713233244_b1-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"key20200713233244_b2-mmr-20-02-1488","first-page":"537","article-title":"Microvascular targets for anti-fibrotic therapeutics","volume":"86","author":"Pu","year":"2013","journal-title":"Yale J Biol Med"},{"key":"key20200713233244_b3-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"key20200713233244_b4-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"764641","DOI":"10.1155\/2015\/764641","article-title":"Fibrosis related inflammatory mediators: Role of the IL-10 cytokine family","volume":"2015","author":"Sziksz","year":"2015","journal-title":"Mediators Inflamm"},{"key":"key20200713233244_b5-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","article-title":"International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"key":"key20200713233244_b6-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cance","volume":"4","author":"Cox","year":"2011","journal-title":"Dis Models Mech"},{"key":"key20200713233244_b7-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J Pathol"},{"key":"key20200713233244_b8-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: One function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"key20200713233244_b9-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key20200713233244_b10-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/01.LAB.0000101911.53973.90","article-title":"Normal and pathologic soft tissue remodeling: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis","volume":"83","author":"Desmouliere","year":"2003","journal-title":"Lab Invest"},{"key":"key20200713233244_b11-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/S0002-9440(10)63598-5","article-title":"Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair","volume":"163","author":"Virag","year":"2003","journal-title":"Am J Pathol"},{"key":"key20200713233244_b12-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","article-title":"The myofibroblast in pulmonary fibrosis","volume":"122","author":"Phan","year":"2002","journal-title":"Chest"},{"key":"key20200713233244_b13-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3899\/jrheum.150088","article-title":"The Endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-\u03b2 and May Be blocked by macitentan, a dual endothelin-1 receptor antagonist","volume":"42","author":"Cipriani","year":"2015","journal-title":"J Rheumatol"},{"key":"key20200713233244_b14-mmr-20-02-1488","first-page":"1","article-title":"The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for systemic sclerosis","volume":"15","author":"Liakouli","year":"2018","journal-title":"Mod Rheumatol"},{"key":"key20200713233244_b15-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41467-017-01168-1","article-title":"PTP4A1 promotes TGF\u03b2 signaling and fibrosis in systemic sclerosis","volume":"8","author":"Sacchetti","year":"2017","journal-title":"Nat Commun"},{"key":"key20200713233244_b16-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","article-title":"Peripheral blood fibrocytes: differentiation pathway and migration to wound sites","volume":"166","author":"Abe","year":"2001","journal-title":"J Immunol"},{"key":"key20200713233244_b17-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1093\/ndt\/gfw388","article-title":"What can target kidney fibrosis?","volume":"32","author":"Leaf","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713233244_b18-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1309\/CNQDMHLH2WGKL32T","article-title":"The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease","volume":"127","author":"Magro","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key20200713233244_b19-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2018.10.015","article-title":"Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury","volume":"70","author":"Ruart","year":"2019","journal-title":"J Hepatol"},{"key":"key20200713233244_b20-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/eji.200939877","article-title":"The pericyte and stromal marker CD248 (endosialin) is required for efficient lymph node expansion","volume":"40","author":"Lax","year":"2010","journal-title":"Eur J Immunol"},{"key":"key20200713233244_b21-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mvr.2008.07.008","article-title":"Endosialin\/TEM1\/CD248 is a pericyte marker of embryonic and tumour neovascularisation","volume":"76","author":"Bagley","year":"2008","journal-title":"Microvasc Res"},{"key":"key20200713233244_b22-mmr-20-02-1488","first-page":"183","article-title":"Endosialin: Molecular and functional links to tumour angiogenesis","volume":"63","author":"Kontsekova","year":"2016","journal-title":"Neoplasma"},{"key":"key20200713233244_b23-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1073\/pnas.0511306103","article-title":"Tumor endothelial marker 1 (TEM1) functions in the growth and progression of abdominal tumours","volume":"103","author":"Nanda","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713233244_b24-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1158\/0008-5472.CAN-16-0932","article-title":"Endosialin-expressing pericytes promote metastatic dissemination","volume":"76","author":"Viski","year":"2016","journal-title":"Cancer Res"},{"key":"key20200713233244_b25-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-018-1719-4","article-title":"Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy","volume":"20","author":"Di Benedetto","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b26-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4161\/cbt.9.11.11731","article-title":"Endosialin\/TEM-1\/CD248 regulates pericyte proliferation through PDGF receptor signaling","volume":"9","author":"Tomkowicz","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"key20200713233244_b27-mmr-20-02-1488","doi-asserted-by":"crossref","first-page":"25429","DOI":"10.18632\/oncotarget.4559","article-title":"Targeting endosialin\/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumour microvasculature","volume":"22","author":"Rybinski","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713233244_b28-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2407-14-113","article-title":"TGF\u03b2-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells","volume":"14","author":"Suresh Babu","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200713233244_b29-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12890-016-0211-7","article-title":"Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis","volume":"16","author":"Bartis","year":"2016","journal-title":"BMC Pulm Med"},{"key":"key20200713233244_b30-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"332","DOI":"10.15252\/emmm.201404246","article-title":"Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage","volume":"7","author":"Mogler","year":"2015","journal-title":"EMBO Mol Med"},{"key":"key20200713233244_b31-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"741","DOI":"10.15252\/emmm.201607222","article-title":"Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin","volume":"9","author":"Mogler","year":"2017","journal-title":"EMBO Mol Med"},{"key":"key20200713233244_b32-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000438754","article-title":"Genetic deletion of the stromal cell marker CD248 (Endosialin) protects against the development of renal fibrosis","volume":"131","author":"Smith","year":"2015","journal-title":"Nephron"},{"key":"key20200713233244_b33-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/gutjnl-2014-308325","article-title":"CD248\/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism","volume":"65","author":"Wilhelm","year":"2016","journal-title":"Gut"},{"key":"key20200713233244_b34-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ki.2011.103","article-title":"CD248+ stromal cells are associated with progressive chronic kidney disease","volume":"80","author":"Smith","year":"2011","journal-title":"Kidney Int"},{"key":"key20200713233244_b35-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.1073\/pnas.89.22.10832","article-title":"Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer","volume":"89","author":"Rettig","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713233244_b36-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/jnen\/63.12.1274","article-title":"Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors","volume":"63","author":"Brady","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20200713233244_b37-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"St Croix","year":"2000","journal-title":"Science"},{"key":"key20200713233244_b38-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.febslet.2005.03.071","article-title":"Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium","volume":"579","author":"MacFadyen","year":"2005","journal-title":"FEBS Lett"},{"key":"key20200713233244_b39-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1002\/art.34556","article-title":"The mesenchymal stem cell marker CD248 (Endosialin) is a negative regulator of bone formation in mice","volume":"64","author":"Naylor","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20200713233244_b40-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1074\/jbc.M009604200","article-title":"Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumour endothelium","volume":"276","author":"Christian","year":"2001","journal-title":"J Biol Chem"},{"key":"key20200713233244_b41-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2174\/138945012799424615","article-title":"CD248: Reviewing its role in health and disease","volume":"13","author":"Valdez","year":"2012","journal-title":"Curr Drug Targets"},{"key":"key20200713233244_b42-mmr-20-02-1488","first-page":"6649","article-title":"Cell surface tumour endothelial markers are conserved in mice and humans","volume":"61","author":"Carson-Walter","year":"2001","journal-title":"Cancer Res"},{"key":"key20200713233244_b43-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1002\/art.27701","article-title":"CD248 and its cytoplasmic domain: A therapeutic target for arthritis","volume":"62","author":"Maia","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20200713233244_b44-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/j.1742-4658.2012.08685.x","article-title":"PDZ-containing proteins as targets in human pathologies","volume":"279","author":"Gardiol","year":"2012","journal-title":"FEBS J"},{"key":"key20200713233244_b45-mmr-20-02-1488","doi-asserted-by":"crossref","first-page":"69420","DOI":"10.18632\/oncotarget.11018","article-title":"Novel antibody probes for the characterization of endosialin\/TEM-1","volume":"7","author":"O'Shannessy","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713233244_b46-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1038\/onc.2017.214","article-title":"Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface","volume":"36","author":"Khan","year":"2017","journal-title":"Oncogene"},{"key":"key20200713233244_b47-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.matbio.2017.04.002","article-title":"The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis","volume":"64","author":"Andreuzzi","year":"2017","journal-title":"Matrix Biol"},{"key":"key20200713233244_b48-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.18632\/oncotarget.6515","article-title":"MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth","volume":"7","author":"Colladel","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713233244_b49-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/onc.2011.487","article-title":"MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A\/VEGFR2 pathway","volume":"31","author":"Lorenzon","year":"2012","journal-title":"Oncogene"},{"key":"key20200713233244_b50-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.matbio.2017.08.003","article-title":"Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium","volume":"64","author":"Galvagni","year":"2017","journal-title":"Matrix Biol"},{"key":"key20200713233244_b51-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"38795","DOI":"10.1074\/jbc.M105241200","article-title":"Molecular characterization of the mouse Tem1\/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo","volume":"276","author":"Opavsky","year":"2001","journal-title":"Biol Chem"},{"key":"key20200713233244_b52-mmr-20-02-1488","first-page":"10","article-title":"Mouse endosialin, a C-type lectin-like cell surface receptor: Expression during embryonic development and induction in experimental cancer neoangiogenesis","volume":"6","author":"Rupp","year":"2006","journal-title":"Cancer Immun"},{"key":"key20200713233244_b53-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.modgep.2006.07.006","article-title":"Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development","volume":"7","author":"MacFadyen","year":"2007","journal-title":"Gene Expr Patterns"},{"key":"key20200713233244_b54-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1016\/j.febslet.2007.06.063","article-title":"CD248\/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair","volume":"581","author":"Lax","year":"2007","journal-title":"FEBS Lett"},{"key":"key20200713233244_b55-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-016-1156-1","article-title":"Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage","volume":"18","author":"Croft","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b56-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jcb.21501","article-title":"TGF-beta signaling: A tale of two responses","volume":"102","author":"Rahimi","year":"2007","journal-title":"J Cell Biochem"},{"key":"key20200713233244_b57-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1586\/14737140.7.5.609","article-title":"Targeted TGF-beta chemotherapies: Friend or foe in treating human malignancies?","volume":"7","author":"Schiemann","year":"2007","journal-title":"Exp Rev Anticancer Ther"},{"key":"key20200713233244_b58-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/14796694.5.2.259","article-title":"The TGF-beta paradox in human cancer: An update","volume":"5","author":"Tian","year":"2009","journal-title":"Future Oncol"},{"key":"key20200713233244_b59-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","article-title":"Hyper-responsiveness of IPF\/UIP fibroblasts: Interplay between TGFbeta1, IL-13 and CCL2","volume":"40","author":"Murray","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"key20200713233244_b60-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1158\/0008-5472.CAN-14-3636","article-title":"Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival","volume":"75","author":"Langenkamp","year":"2015","journal-title":"Cancer Res"},{"key":"key20200713233244_b61-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1182\/blood-2011-01-332338","article-title":"Pericytes promote selective vessel regression to regulate vascular patterning","volume":"120","author":"Simonavicius","year":"2012","journal-title":"Blood"},{"key":"key20200713233244_b62-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1158\/1078-0432.CCR-08-0499","article-title":"Endosialin protein expression and therapeutic target potential in human solid tumors: Sarcoma versus carcinoma","volume":"14","author":"Rouleau","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200713233244_b63-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/wrr.12542","article-title":"Isolation of CD248-expressing stromal vascular fraction for targeted improvement of wound healing","volume":"25","author":"Brett","year":"2017","journal-title":"Wound Repair Regen"},{"key":"key20200713233244_b64-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"e107146","DOI":"10.1371\/journal.pone.0107146","article-title":"A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis","volume":"22","author":"Naylor","year":"2014","journal-title":"PLoS One"},{"key":"key20200713233244_b65-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1172\/JCI67382","article-title":"Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature","volume":"124","author":"Facciponte","year":"2014","journal-title":"J Clin Invest"},{"key":"key20200713233244_b66-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0959-437X(00)00156-8","article-title":"Know thy neighbor: Stromal cells can contribute oncogenic signals","volume":"11","author":"Tlsty","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"key20200713233244_b67-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1101\/sqb.2005.70.013","article-title":"Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes","volume":"70","author":"Bissell","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"key20200713233244_b68-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"key20200713233244_b69-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.1158\/0008-5472.CAN-05-1702","article-title":"Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713233244_b70-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12307-014-0151-9","article-title":"Tumor-driven molecular changes in human mesenchymal stromal cells","volume":"8","author":"Kucerova","year":"2015","journal-title":"Cancer Microenviron"},{"key":"key20200713233244_b71-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know?","volume":"100","author":"Nagy","year":"2009","journal-title":"Br J Cancer"},{"key":"key20200713233244_b72-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12307-015-0168-8","article-title":"Endosialin expression in metastatic melanoma tumor microenvironment vasculature: Potential therapeutic implications","volume":"8","author":"Kiyohara","year":"2015","journal-title":"Cancer Microenviron"},{"key":"key20200713233244_b73-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.bjc.6604685","article-title":"Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2","volume":"99","author":"Ohradanova","year":"2008","journal-title":"Br J Cancer"},{"key":"key20200713233244_b74-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat Med"},{"key":"key20200713233244_b75-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2478\/jtim-2018-0018","article-title":"Hypoxia-inducible factor may induce the development of liver fibrosis in budd-chiari syndrome by regulating CD248\/endosialin Expression: A Hypothesis","volume":"6","author":"Tian","year":"2018","journal-title":"J Transl Int Med"},{"key":"key20200713233244_b76-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ajpath.2010.10.012","article-title":"Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis","volume":"178","author":"Lin","year":"2011","journal-title":"Am J Pathol"},{"key":"key20200713233244_b77-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1074\/mcp.M113.031344","article-title":"SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers","volume":"12","author":"Zanivan","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"key20200713233244_b78-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"key20200713233244_b79-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/ar4606","article-title":"Imatinib in Scleroderma Italian Study Group. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: A phase II pilot study","volume":"16","author":"Fraticelli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b80-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7113-8_1","article-title":"Human fibrotic diseases: Current challenges in fibrosis research","volume":"1627","author":"Rosenbloom","year":"2017","journal-title":"Methods Mol Biol"},{"key":"key20200713233244_b81-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun Rev"},{"key":"key20200713233244_b82-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2188","article-title":"Fibrosis in connective tissue disease: The role of the myofibroblast and fibroblast-epithelial cell interactions","volume":"9","author":"Krieg","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b83-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3899\/jrheum.150996","article-title":"Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis","volume":"43","author":"Cipriani","year":"2016","journal-title":"J Rheumatol"},{"key":"key20200713233244_b84-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","article-title":"Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts","volume":"17","author":"Cipriani","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b85-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1247\/csf.28.105","article-title":"Hepatic stellate cells: Unique characteristics in cell biology and phenotype","volume":"28","author":"Sato","year":"2003","journal-title":"Cell Struct Funct"},{"key":"key20200713233244_b86-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am J Pathol"},{"key":"key20200713233244_b87-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","article-title":"Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: A link between vascular and fibrotic features","volume":"16","author":"Cipriani","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"key20200713233244_b88-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","article-title":"Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine","volume":"16","author":"Cipriani","year":"2013","journal-title":"Angiogenesis"},{"key":"key20200713233244_b89-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.2848","article-title":"Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury","volume":"18","author":"Dulauroy","year":"2012","journal-title":"Nat Med"},{"key":"key20200713233244_b90-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000440890","article-title":"CD248\/Endosialin: A novel pericyte target in renal fibrosis","volume":"131","author":"Chang-Panesso","year":"2015","journal-title":"Nephron"},{"key":"key20200713233244_b91-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ki.2011.208","article-title":"Platelet-derived growth factor receptor signalling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis","volume":"80","author":"Chen","year":"2011","journal-title":"Kidney Int"},{"key":"key20200713233244_b92-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"828","DOI":"10.5114\/aoms.2016.60970","article-title":"Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis","volume":"12","author":"Cipriani","year":"2016","journal-title":"Arch Med Sci"},{"key":"key20200713233244_b93-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"i45","DOI":"10.1093\/ndt\/gft273","article-title":"PDGF and the progression of renal disease","volume":"29","author":"Boor","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713233244_b94-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: Paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am J Pathol"},{"key":"key20200713233244_b95-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/ijc.23925","article-title":"Stromal myofibroblasts are drivers of invasive cancer growth","volume":"123","author":"De Wever","year":"2008","journal-title":"Int J Cancer"},{"key":"key20200713233244_b96-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-011-9340-x","article-title":"Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression","volume":"31","author":"Cirri","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"key20200713233244_b97-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200713233244_b98-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20200713233244_b99-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-319-51436-9_13","article-title":"Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): Role and implications in kidney fibrosis","volume":"60","author":"Cruz-Solbes","year":"2017","journal-title":"Results Probl Cell Differ"},{"key":"key20200713233244_b100-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-physiol-012110-142225","article-title":"Epithelial-mesenchymal interactions in pulmonary fibrosis","volume":"73","author":"Chapman","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"key20200713233244_b101-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","article-title":"Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders","volume":"179","author":"Piera-Velazquez","year":"2011","journal-title":"Am J Pathol"},{"key":"key20200713233244_b102-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/ATVBAHA.111.231548","article-title":"Myofibroblast-mediated adventitial remodeling: An underestimated player in arterial pathology","volume":"31","author":"Coen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713233244_b103-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s12272-016-0787-8","article-title":"Inflammatory fibroblasts in cancer","volume":"39","author":"Lim","year":"2016","journal-title":"Arch Pharm Res"},{"key":"key20200713233244_b104-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"key20200713233244_b105-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"key20200713233244_b106-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713233244_b107-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: Paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J Biomech"},{"key":"key20200713233244_b108-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/cam.20377","article-title":"The role of the myofibroblast in tumor stroma remodeling","volume":"6","author":"Otranto","year":"2012","journal-title":"Cell Adh Migr"},{"key":"key20200713233244_b109-mmr-20-02-1488","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.12.003","article-title":"Cancer-associated fibroblasts in tumor microenvironment-Accomplices in tumor malignancy","author":"Liao","year":"2018","journal-title":"Cell Immunol"},{"key":"key20200713233244_b110-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fcell.2018.00131","article-title":"Macrophages and fibroblasts, key players in cancer chemoresistance","volume":"6","author":"Ireland","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"key20200713233244_b111-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm.1908","article-title":"A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer","volume":"15","author":"Farmer","year":"2009","journal-title":"Nat Med"},{"key":"key20200713233244_b112-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.cgh.2009.07.039","article-title":"Desmoplasia of pancreatic ductal adenocarcinoma","author":"Pandol","year":"2009","journal-title":"Clin Gastroenterol Hepatol 7 (11 Suppl)"},{"key":"key20200713233244_b113-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1053\/j.gastro.2016.03.040","article-title":"Mounting pressure in the microenvironment: Fluids, solids, and cells in pancreatic ductal adenocarcinoma","volume":"150","author":"DuFort","year":"2016","journal-title":"Gastroenterology"},{"key":"key20200713233244_b114-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2353\/ajpath.2008.070623","article-title":"Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells","volume":"172","author":"Christian","year":"2008","journal-title":"Am J Pathol"},{"key":"key20200713233244_b115-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/cam4.515","article-title":"TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer","volume":"4","author":"Fujii","year":"2015","journal-title":"Cancer Med"},{"key":"key20200713233244_b116-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/1078-0432.CCR-14-1829","article-title":"A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors","volume":"21","author":"Diaz","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713233244_b117-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"e26944","DOI":"10.1002\/pbc.26944","article-title":"Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)","volume":"65","author":"Norris","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"key20200713233244_b118-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10637-017-0530-4","article-title":"A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma","volume":"36","author":"D'Angelo","year":"2018","journal-title":"Invest New Drugs"},{"key":"key20200713233244_b119-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1158\/1078-0432.CCR-17-1558","article-title":"A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of monotherapy ontuxizumab (MORAb-004) plus best supportive care in patients with chemorefractory metastatic colorectal cancer","volume":"24","author":"Grothey","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20200713233244_b120-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/1535-7163.MCT-15-0312","article-title":"Anti-endosialin antibody-drug conjugate: Potential in sarcoma and other malignancies","volume":"14","author":"Rouleau","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"key20200713233244_b121-mmr-20-02-1488","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1755-148X.2010.00706.x","article-title":"What tumor vessels can tell us","volume":"23","author":"Lee","year":"2010","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:25:13Z","timestamp":1594686313000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":121,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10429","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]}}}